Your Messages Inbox
Your Article Summary
See Latest ArticlesQuantifying the hidden lactose in drugs used for the treatment of gastrointestinal conditions
Alimentary Pharmacology and Therapeutics, 02/16/09
Eadala P et al. - Lactose is present in a range of medications and may contribute towards symptoms. This may not be recognized by the prescribing doctor as excipients are not listed in the BNF, and the quantity of lactose is not listed on the label or in the accompanying manufacturer's leaflet.
Related Articles
Sleep Apnea Sufferers at Risk for GI Conditions
Ivanhoe, 10/09/09
Relevance Score: 65%
OxyR, a LysR-type regulator involved in Klebsiella pneumoniae mucosal and abiotic colonization
Infection and Immunity, 10/06/09
Relevance Score: 65%
Many patients with sleep apnea also suffer from GI tract conditions
EurekAlert, 10/05/09
Relevance Score: 65%
Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination
Gastric Cancer, 11/11/09
Relevance Score: 64%
Changes in Quality-of-Life Following Laparoscopic Cholecystectomy in Adult Patients with Cholelithiasis
Journal of Gastrointestinal Surgery, 10/20/09
Relevance Score: 64%
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical and minimally invasive treatments for Peyronie's disease
Current Opinion in Urology, 11/19/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Derivation and Validation of the ASK-12 Adherence Barrier Survey
Annals of Pharmacotherapy, 10/15/09
Article Search
Sponsor